title: Update on a proper use of systemic fluoroquinolones in adult patients (ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, pefloxacin. SPILF.).
authors.affiliation: CIRI Inserm U1111, maladies infectieuses et tropicales, université Claude-Bernard-Lyon 1, UFR Lyon Sud-Charles-Mérieux, GHN HCL, 69500 Lyon, France. Electronic address: christian.chidiac@univ-lyon1.fr.
authors.forename: C
authors.initials: C
authors.lastname: Chidiac
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D001424:Bacterial Infections / Q000188:drug therapy; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors / Q000235:genetics; D001711:Biotransformation; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002648:Child; D000075202:Contraindications; D027081:DNA Gyrase / Q000235:genetics; D027101:DNA Topoisomerase IV / Q000235:genetics; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics; D005260:Female; D024841:Fluoroquinolones / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005602:France; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced; D008297:Male; D009154:Mutation; D010787:Photosensitivity Disorders / Q000139:chemically induced; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D052256:Tendinopathy / Q000139:chemically induced; D014018:Tissue Distribution; D059005:Topoisomerase II Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D024841:Fluoroquinolones; D059005:Topoisomerase II Inhibitors; D027101:DNA Topoisomerase IV; D027081:DNA Gyrase